AU2001276378A1 - Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme - Google Patents
Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzymeInfo
- Publication number
- AU2001276378A1 AU2001276378A1 AU2001276378A AU7637801A AU2001276378A1 AU 2001276378 A1 AU2001276378 A1 AU 2001276378A1 AU 2001276378 A AU2001276378 A AU 2001276378A AU 7637801 A AU7637801 A AU 7637801A AU 2001276378 A1 AU2001276378 A1 AU 2001276378A1
- Authority
- AU
- Australia
- Prior art keywords
- beta
- enzyme
- regulation
- human
- hydroxysteroid dehydrogenase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01146—11-Beta-hydroxysteroid dehydrogenase (1.1.1.146)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21635000P | 2000-07-05 | 2000-07-05 | |
US60/216,350 | 2000-07-05 | ||
US23129500P | 2000-09-08 | 2000-09-08 | |
US60/231,295 | 2000-09-08 | ||
PCT/EP2001/007632 WO2002002797A2 (fr) | 2000-07-05 | 2001-07-04 | Regulation d'enzyme du type 11 beta-hydroxysteroide deshydrogenase 1 humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001276378A1 true AU2001276378A1 (en) | 2002-01-14 |
Family
ID=26910926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001276378A Abandoned AU2001276378A1 (en) | 2000-07-05 | 2001-07-04 | Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1309697A2 (fr) |
JP (1) | JP2004502432A (fr) |
AU (1) | AU2001276378A1 (fr) |
WO (1) | WO2002002797A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1348021A2 (fr) * | 2000-11-30 | 2003-10-01 | Millenium Pharmaceuticals, Inc. | 25206, nouveau membre humain de la famille deshydrogenase/reductase a chaine courte et utilisations de celui-ci |
GB0107383D0 (en) * | 2001-03-23 | 2001-05-16 | Univ Edinburgh | Lipid profile modulation |
WO2004075831A2 (fr) * | 2003-02-21 | 2004-09-10 | Merck & Co., Inc. | Dosage pharmacodynamique d'inhibiteurs de l'activite 11-beta-hydroxysteroide deshydrogenase dans les tissus animaux |
US20040180332A1 (en) * | 2003-03-12 | 2004-09-16 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating aids and HIV-related disorders using 9145, 1725, 311, 837, 58305, 156, 14175, 50352, 32678, 5560, 7240, 8865, 12396, 12397, 13644, 19938, 2077, 1735, 1786, 10220, 17822, 33945, 43748, 47161, 81982 or 46777 |
US7501405B2 (en) | 2003-04-11 | 2009-03-10 | High Point Pharmaceuticals, Llc | Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders |
EP1862181A3 (fr) * | 2003-04-11 | 2010-09-15 | High Point Pharmaceuticals, LLC | Polythérapie utilisant un inhibiteur de la 11B-hydroxystéroïde déshydrogénase de type 1 et agent anti-hypertensif pour le traitement du syndrome métabolique et maladies et troubles associés |
WO2004089416A2 (fr) * | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Polytherapie utilisant un inhibiteur de type 1 de la 11beta-hydroxysteroide deshydrogenase et un agent hypotenseur dans le traitement du syndrome metabolique et des troubles et maladies associes |
WO2005119525A1 (fr) * | 2004-06-04 | 2005-12-15 | Pfizer Products Inc. | Structures cristallines de 11?hsd1 utilisees pour la conception de medicaments |
WO2006059507A1 (fr) * | 2004-11-30 | 2006-06-08 | Sankyo Company, Limited | Compose antisens 11?-hsd1 |
AU2006316087B2 (en) | 2005-11-21 | 2011-03-10 | Shionogi & Co., Ltd. | Heterocyclic compound having inhibitory activity on 11-beta-hydroxysteroid dehydrogenase type I |
BRPI0811191A2 (pt) | 2007-05-18 | 2014-10-29 | Shionogi & Co | Derivado heterocíclico contendo nitrogênio tendo atividade inibitória para 11beta-hidroxiesteroide deidrogenase tipo 1 |
WO2010059618A1 (fr) | 2008-11-21 | 2010-05-27 | High Point Pharmaceuticals, Llc | Adamantylbenzamides |
US8513430B2 (en) | 2010-07-27 | 2013-08-20 | High Point Pharmaceuticals, Llc | Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965372A (en) * | 1995-08-24 | 1999-10-12 | Baker Medical Research Institute | Genetic sequences encoding glucocorticoid dehydrogenases and uses thereof |
SE0001899D0 (sv) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
-
2001
- 2001-07-04 WO PCT/EP2001/007632 patent/WO2002002797A2/fr not_active Application Discontinuation
- 2001-07-04 JP JP2002508037A patent/JP2004502432A/ja active Pending
- 2001-07-04 EP EP01954005A patent/EP1309697A2/fr not_active Withdrawn
- 2001-07-04 AU AU2001276378A patent/AU2001276378A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002002797A2 (fr) | 2002-01-10 |
EP1309697A2 (fr) | 2003-05-14 |
JP2004502432A (ja) | 2004-01-29 |
WO2002002797A3 (fr) | 2003-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001247788A1 (en) | 32142, 21481, 25964, 21686, novel human dehydrogenase molecules and uses therefor | |
AU2001276378A1 (en) | Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme | |
AU5721898A (en) | Subunits of nadh dehydrogenase | |
AU1775299A (en) | Plant galactose dehydrogenase | |
AU2001283872A1 (en) | Regulation of human eosinophil serine protease 1-like enzyme | |
AU2001281939A1 (en) | Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme | |
AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
AU2001237592A1 (en) | Enzymes and uses relating thereto | |
AU2001251122A1 (en) | Tyr393 and tyr398 mutants of monoamine oxidase b | |
AU2001251668A1 (en) | 39228, a human alcohol dehydrogenase and uses therefor | |
AU2001281950A1 (en) | Regulation of human thimet oligopeptidase-like enzyme | |
AU2001262291A1 (en) | Enzymatic oxidation composition and process | |
AU4415501A (en) | Regulation of human gelatinase b-like enzyme 1 | |
AUPP697698A0 (en) | Regulation of enzyme activity | |
AU7242301A (en) | Regulation of human polyamine oxidase-like enzyme | |
AU5780999A (en) | Genes that regulate hematopoietic blood forming stem cells and uses thereof | |
AU2002215942A1 (en) | Regulation of human carboxylesterase-like enzyme | |
AU2002210525A1 (en) | Regulation of human phospholipase-like enzyme | |
AU2001285782A1 (en) | Regulation of human phosphodiesterase-like enzyme | |
AU2001281969A1 (en) | Regulation of human carboxylesterase-like enzyme | |
AU2002212246A1 (en) | Regulation of human serine palmitoyltransferase-like enzyme | |
AU2002220556A1 (en) | Regulation of human pristanoyl-coa oxidase-like enzyme | |
AU2002212318A1 (en) | Regulation of human phospholipase a2-like enzyme | |
AU2001295602A1 (en) | Regulation of human phospholipase a2-like enzyme | |
AU5033101A (en) | Regulation of human heparanase-like enzyme |